We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




IV System Designed to Eliminate Drug Errors

By HospiMedica staff writers
Posted on 23 May 2002
A new intravenous (IV) system is designed to ensure that the correct patient is receiving the correct drug in the correct dose. More...
The system was introduced at the National Teaching Institute of the American Asssociation of Critical Care Nurses in Atlanta (GA, USA).

The most common sources of errors in IV drug administration involve either the wrong patient, the wrong drug, or the wrong dosage. The new IV system is intended to eliminate these errors by safety measures that affect labeling, patient-medication matching, and infusion pumps. The system, called Horizon Outlook IV, generates a bar code label on the IV medication bag. At bedside, caregivers must scan a bar code on their badge to verify authorization, scan the patient's identification bar code to identify the patient, scan the bar code on the medication to confirm it matches the patient, and scan the infusion parameters on the IV bag to program the infusion bag. If the bar codes correlate, the infusion pump will confirm that the information is correct and infusion can be initiated.

The Horizon Outlook IV is the product of B. Braun Medical, Inc. (Bethlehem, PA, USA). The system incorporates DoseScan technology with open architecture that enables it to interface with any hospital or pharmacy information management system. Hospitals without a pharmacy system can use a software package to generate bar codes.

"Because it integrates with the existing pharmacy information system, the Horizon Outlook IV system can automatically accommodate any drug on the hospital formulary,” said Sheila Kempf, vice president of marketing at Braun. "The system is not limited to a specific number of preprogrammed drugs.”




Related Links:
B. Braun

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.